Muser J, Kaech S, Moroni C, Ballmer-Hofer K
Friedrich Miescher-Institut, Basel, Switzerland.
Oncogene. 1989 Dec;4(12):1433-9.
Either of two hematopoietic growth factors, GM-CSF or IL-3, are required for the growth of the bone marrow-derived FDC-P1 cell line. These factors induce cellular tyrosine-specific protein kinases when added to resting cells. The receptors for these factors have not been unambiguously shown to contain a kinase domain. To determine whether src-related kinases, in particular pp60-c-src, are regulated by GM-CSF or IL-3, FDC-P1 cells were transfected with plasmids carrying polyoma middle-T antigen, a potent activator of pp60c-src. Middle-T-expressing cells showed a reduced requirement for GM-CSF and IL-3 and selected clones grew in the absence of these factors. Middle-T formed a complex with pp60c-src and stimulated its in vitro kinase activity 20-50 fold. pp60c-src kinase activity was further increased if middle-T-expressing, factor-independent cells were treated with GM-CSF or IL-3.
骨髓来源的FDC-P1细胞系的生长需要两种造血生长因子之一,即粒细胞-巨噬细胞集落刺激因子(GM-CSF)或白细胞介素-3(IL-3)。这些因子添加到静息细胞中时会诱导细胞酪氨酸特异性蛋白激酶。这些因子的受体尚未明确显示含有激酶结构域。为了确定与src相关的激酶,特别是pp60-c-src,是否受GM-CSF或IL-3调节,用携带多瘤病毒中T抗原(一种有效的pp60c-src激活剂)的质粒转染FDC-P1细胞。表达中T的细胞对GM-CSF和IL-3的需求降低,所选克隆在没有这些因子的情况下也能生长。中T与pp60c-src形成复合物,并将其体外激酶活性刺激20至50倍。如果用GM-CSF或IL-3处理表达中T的、不依赖因子的细胞,pp60c-src激酶活性会进一步增加。